Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 161 participants.
Also called NCT04458103
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 161 participants
- Registry
-
NCT04458103
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT04458103. Non-randomized; no masking; primary purpose prevention. Start 2020-05-12 (actual); primary completion 2022-06-01 (actual). Results posted on 2024-07-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD
- Condition
- Heart Failure
- Intervention (Device)
- Percutaneous RVAD
- Lead sponsor
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct04458103- Content hash
ae334fa4c31afda3d108cd298788f07015f3bdebb3b0d6eec77ea8a125cca1a2